To reiterate, I don’t see the MRK-INSM deal as being especially relevant to GTC.
If, instead of acquiring INSM’s assets, MRK had announced that it was breaking ground on a new bioreactor to support its push into biologics, would you have touted that as a bullish development for GTC?
MRK’s actual announcement that it is acquiring INSM’s Boulder, CO facility and staff simply means that MRK was able to acquire these assets from INSM more cheaply than it would have cost to build them from scratch.
Market Data 
Markets 
AI
